STOCK TITAN

LevelJump Healthcare Announces Grant of Options

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (FSE: 75J) announces the grant of 2,650,000 stock options to certain directors and officers, as well as the expiration of 3,900,000 previous options. The new options were granted at an exercisable price of $0.20 and are subject to 12-month vesting provisions, expiring on December 31, 2026.
Positive
  • None.
Negative
  • None.

Toronto, Ontario--(Newsfile Corp. - January 11, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTC Pink: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, announces that it has granted 2,650,000 stock options to certain directors and officers of the Company.

In light of the new Option grant, the Company would also like to announce that as of December 21, 2023 and December 31, 2023, 3,900,000 previous directors and officers Options have expired.

Of the Options granted:

  • An aggregate of 2,650,000 Options at an exercisable price of $0.20 were granted to certain directors of the Company expiring December 31, 2026 and are subject to 12 month vesting provisions.

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF's (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler
Chief Executive Officer

Caitlin-Robyn Densmore
Investor Relations Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/193946

FAQ

How many stock options were granted by LevelJump Healthcare Corp. (JUMP)?

LevelJump Healthcare Corp. granted 2,650,000 stock options to certain directors and officers.

What is the exercisable price of the new options granted by LevelJump Healthcare Corp. (JUMP)?

The new options were granted at an exercisable price of $0.20.

When do the new options granted by LevelJump Healthcare Corp. (JUMP) expire?

The new options granted by LevelJump Healthcare Corp. expire on December 31, 2026.

How many previous options expired for LevelJump Healthcare Corp. (JUMP)?

3,900,000 previous options expired for LevelJump Healthcare Corp.

What are the vesting provisions for the new options granted by LevelJump Healthcare Corp. (JUMP)?

The new options are subject to 12-month vesting provisions.

LEVELJUMP HEALTHCARE CP

OTC:JMPHF

JMPHF Rankings

JMPHF Latest News

JMPHF Stock Data

3.48M
70.82M
26.58%
Diagnostics & Research
Healthcare
Link
United States of America
Toronto